BRIEF-Sarepta Therapeutics Posts Q4 Loss Per Share Of $2.40
BRIEF-Sarepta Therapeutics Posts Q4 Loss Per Share Of $2.40
* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q4 NON-GAAP LOSS PER SHARE $1.84
* Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
* NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
* QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
* QTRLY LOSS PER SHARE $2.40
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
March 1 (Reuters) - Sarepta Therapeutics Inc :
* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q4 NON-GAAP LOSS PER SHARE $1.84
* Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
* NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
* QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
* QTRLY LOSS PER SHARE $2.40
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透3月1日电-Sarepta治疗公司：*Sarepta治疗公司宣布2020年第四季度和全年的财务业绩和最近的公司发展*第四季度非GAAP每股亏损1.84美元*第四季度每股收益预估-1.87美元-REFINITIV IBES数据*第四季度产品净销售额为1.226亿美元*qtrly总收入为1.451亿美元，而不是1.01亿美元*Qtrly每股亏损2.40美元Eikon的源文本：进一步的公司报道：(Reurs.Briefs@thomsonreurs.com；)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧